Remdesivir cuts COVID-19 death risk by 62%, drugmaker says

The antiviral drug remdesivir has demonstrated that it can lower the risk of death in COVID-19 patients, U.S. drugmaker Gilead Sciences reported in new data Friday.

Source: Health News - UPI.com - July 10, 2020 Category: Consumer Health News Source Type: news